Dr. Varun Renjen

Varun is a physician with over 11 years of experience in strategy consulting in the life sciences industry with additional academic medical research experience. His areas of focus are commercial strategy, growth strategy, medical affairs and M&A for life science companies worldwide. He has supported both big pharma companies as well as emerging earlier stage companies on a variety of strategic issues. As a trained physician, Varun has worked and supported across all therapeutic areas focus and has been a clinical SME across projects.

A particular focus is in the growing field of CNS in both neurology and psychiatry Varun has supported biopharma clients in CNS across a variety of strategic issues including disease area strategy, portfolio strategy and optimization, corporate strategy, pricing and market access, medical affairs strategy, and M&A strategy for inorganic growth. He has published thought leadership on a variety of CNS topics and has attended several CNS specific conferences over the course of his career.

Professional and Industry Experience:

• CNS disease area strategy for leading CNS company for a 5-10 year horizon 
• Corporate strategy for leading CNS company focused on inorganic growth strategy 
• Portfolio optimization for leading CNS company to help maximize R&D investment across prioritized developmental programs 
• Cell and gene therapy disease area strategy over 10 year period with focus on solid tumor development 
• Immunology disease area strategy with focus on organic and inorganic growth over 10 year period 
• Biomarker strategy for leading company interested in developing novel assets for 1L DLBCL 
• Commercial due diligence for novel Parkinson’s disease modifying therapy